We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$21.2B
AUM Growth
+$2.31B
Cap. Flow
+$622M
Cap. Flow %
2.93%
Top 10 Hldgs %
15.94%
Holding
1,089
New
178
Increased
395
Reduced
238
Closed
219

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$215M
2
T icon
AT&T
T
+$206M
3
KEYS icon
Keysight
KEYS
+$199M
4
AMZN icon
Amazon
AMZN
+$154M
5
NXPI icon
NXP Semiconductors
NXPI
+$149M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$224M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$216M
3
TER icon
Teradyne
TER
+$137M
4
BRO icon
Brown & Brown
BRO
+$120M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$116M

Sector Composition

Rank Sector Weight
1 Technology 25.42%
2 Healthcare 23.84%
3 Financials 10.35%
4 Consumer Discretionary 9.93%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLOB icon
851
Globant
GLOB
$1.61B
$386K ﹤0.01%
6,722
+1,827
+37% +$134K
KALA icon
852
KALA BIO
KALA
$14.2M
$379K ﹤0.01%
4,949
-1,054
-18% -$523K
INGM
853
Ingram Micro Holding
INGM
$6.59B
$371K ﹤0.01%
17,284
– –
AGYS icon
854
Agilysys
AGYS
$3.03B
$351K ﹤0.01%
3,335
+267
+9% +$29.5K
SLN
855
Silence Therapeutics
SLN
$554M
$324K ﹤0.01%
62,459
– –
CARL
856
Carlsmed
CARL
$372M
$311K ﹤0.01%
+23,210
New +$317K
DAVA icon
857
Endava
DAVA
$154M
$275K ﹤0.01%
+30,229
New +$376K
CASI
858
DELISTED
CASI Pharmaceuticals
CASI
$275K ﹤0.01%
165,640
– –
NSP icon
859
Insperity
NSP
$1.96B
$266K ﹤0.01%
5,400
-1,561
-22% -$85.5K
UAA icon
860
Under Armour
UAA
$2.73B
$235K ﹤0.01%
47,044
– –
OTIS icon
861
Otis Worldwide
OTIS
$28.1B
$231K ﹤0.01%
+2,525
New +$229K
ALIT icon
862
Alight
ALIT
$411M
$204K ﹤0.01%
+3,131
New +$277K
PRQR icon
863
ProQR Therapeutics
PRQR
$268M
$196K ﹤0.01%
92,140
-1,411,860
-94% -$3.08M
BIOA
864
BioAge Labs
BIOA
$501M
$186K ﹤0.01%
31,565
– –
XPOF icon
865
Xponential Fitness
XPOF
$266M
$181K ﹤0.01%
23,274
– –
VTYX
866
DELISTED
Ventyx Biosciences
VTYX
$143K ﹤0.01%
+45,826
New +$121K
ATYR
867
aTyr Pharma
ATYR
$49.2M
$74.1K ﹤0.01%
102,687
-1,578,908
-94% -$7.15M
CAPR icon
868
Capricor Therapeutics
CAPR
$242M
$72.9K ﹤0.01%
10,117
-231,527
-96% -$1.7M
NMRA icon
869
Neumora Therapeutics
NMRA
$304M
$27.2K ﹤0.01%
14,957
– –
SGMO
870
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$19.4K ﹤0.01%
28,859
– –
ACLS icon
871
Axcelis
ACLS
$4.2B
– –
-4,159
Closed -$290K
ADCT icon
872
ADC Therapeutics
ADCT
$144M
– –
-842,900
Closed -$2.26M
ADT icon
873
ADT
ADT
$5.59B
– –
-59,372
Closed -$503K
AJG icon
874
Arthur J. Gallagher & Co
AJG
$64.5B
– –
-363,575
Closed -$116M
AKBA icon
875
Akebia Therapeutics
AKBA
$256M
– –
-1,001,360
Closed -$3.64M
33 34
35
36 37

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Woodline Partners held 1,089 positions worth $21.2B, up 12% from $18.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners's Q3 2025 filing shows 178 new, 395 increased, 238 reduced and 219 closed positions. Its largest new stake was Chubb: 780,221 shares worth $220M. The largest sale was Meta Platforms (Facebook), an estimated $224M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Woodline Partners's largest Q3 2025 buy was Chubb: 780,221 shares worth $220M.
  • Woodline Partners added most to AT&T in Q3 2025, an estimated $206M increase.
  • Woodline Partners's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $224M.
  • Woodline Partners fully exited Brown & Brown in Q3 2025, selling an estimated $120M.
  • Woodline Partners's ten largest holdings make up 16% of its $21.2B portfolio in Q3 2025.
  • Woodline Partners opened 178 new positions and closed 219 in Q3 2025.
  • Woodline Partners's portfolio value rose 12% quarter-over-quarter to $21.2B.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.